Tomasz Litwin Selected Research

Tomasz Litwin Research Topics

Disease

68	Hepatolenticular Degeneration (Wilson's Disease) 04/2024 - 04/2008
13	Inborn Genetic Diseases (Disease, Hereditary) 08/2023 - 03/2013
6	Neurologic Manifestations (Neurological Manifestations) 01/2023 - 08/2015
5	Disease Progression 04/2024 - 09/2013
5	Brain Injuries (Brain Injury) 02/2022 - 04/2008
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2021
2	Atrophy 11/2020 - 10/2019
2	Liver Diseases (Liver Disease) 04/2019 - 01/2019
2	Fibrosis (Cirrhosis) 01/2019 - 03/2015
2	Liver Failure 07/2018 - 03/2015
2	Multiple Sclerosis 01/2018 - 03/2017
2	Parkinson Disease (Parkinson's Disease) 01/2015 - 10/2004
2	Stroke (Strokes) 01/2012 - 01/2008
1	Drug-Related Side Effects and Adverse Reactions 04/2024
1	Myasthenia Gravis 08/2023
1	Spinal Cord Diseases 07/2023
1	Pancytopenia 07/2023
1	Chorea (Rheumatic Chorea) 07/2023
1	Tremor (Tremors) 07/2023
1	Dystonia (Limb Dystonia) 07/2023
1	Deglutition Disorders (Dysphagia) 07/2023
1	Dysarthria (Spastic Dysarthria) 07/2023
1	Parkinsonian Disorders (Parkinsonism) 07/2023
1	Autoimmune Diseases (Autoimmune Disease) 09/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 02/2022
1	Nervous System Trauma 01/2022
1	Dementia (Dementias) 11/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2020
1	Neurodegeneration with brain iron accumulation (NBIA) 11/2020
1	Infections 01/2020
1	Gliosis 04/2019
1	Cataract (Cataracts) 04/2019
1	Demyelinating Diseases (Demyelinating Disease) 04/2019
1	Cognitive Dysfunction 01/2019
1	Relapsing-Remitting Multiple Sclerosis 01/2018
1	Brain Diseases (Brain Disorder) 03/2015
1	Inflammation (Inflammations) 01/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2013
1	Ischemic Stroke 01/2008
1	Seizures (Absence Seizure) 02/2007

Drug/Important Bio-Agent (IBA)

57	CopperIBA 04/2024 - 04/2008
8	IronIBA 09/2022 - 05/2012
7	Penicillamine (Cuprimine)FDA Link 08/2023 - 02/2014
5	Copper Transport ProteinsIBA 04/2023 - 10/2018
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
3	AntioxidantsIBA 04/2023 - 02/2014
3	Zinc Sulfate FDA Link 09/2022 - 08/2015
3	Proteins (Proteins, Gene)FDA Link 09/2022 - 01/2015
3	ZincIBA 01/2017 - 01/2014
2	Ceruloplasmin (Ferroxidase)IBA 10/2019 - 01/2015
2	Fingolimod Hydrochloride (FTY720)FDA Link 01/2018 - 03/2017
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2012 - 01/2008
1	muskIBA 08/2023
1	AntibodiesIBA 08/2023
1	Edrophonium (Tensilon)FDA LinkGeneric 08/2023
1	Phosphotransferases (Kinase)IBA 08/2023
1	Cholinergic ReceptorsIBA 08/2023
1	AutoantibodiesIBA 09/2022
1	CollagenIBA 01/2021
1	Mitochondrial DNA (mtDNA)IBA 11/2020
1	UreaseIBA 01/2020
1	Tyrosine (L-Tyrosine)FDA Link 11/2019
1	Phenylalanine (L-Phenylalanine)FDA Link 11/2019
1	Histidine (L-Histidine)FDA Link 11/2019
1	Choline (Choline Chloride)IBA 11/2019
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 11/2019
1	Methionine (L-Methionine)FDA Link 11/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	Polycomb Repressive Complex 1IBA 01/2019
1	hydrogen sulfite (bisulfite)IBA 01/2019
1	ThioredoxinsIBA 11/2018
1	siponimodIBA 01/2018
1	Natalizumab (Tysabri)FDA Link 01/2018
1	SaltsIBA 01/2017
1	Chelating AgentsIBA 01/2017
1	Retinaldehyde (Retinal)IBA 04/2016
1	Dopamine AntagonistsIBA 08/2015
1	MetalsIBA 02/2015
1	ManganeseIBA 02/2015
1	Familial apoceruloplasmin deficiencyIBA 02/2015
1	SynucleinsIBA 01/2015
1	TeaIBA 01/2015
1	MetalloproteinsIBA 01/2015
1	Adenosine Triphosphatases (ATPase)IBA 01/2014
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2013
1	Antihypertensive Agents (Antihypertensives)IBA 01/2012
1	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/2008
1	Blood Glucose (Blood Sugar)IBA 02/2007
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2004

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2014
3	Liver Transplantation 04/2022 - 04/2008
2	Aftercare (After-Treatment) 06/2023 - 01/2017
1	Transcranial Magnetic Stimulation 03/2023
1	Time-to-Treatment 01/2012
1	Thrombolytic Therapy 01/2008